A new trading day began on Monday, with Compass Therapeutics Inc (NASDAQ: CMPX) stock price up 5.56% from the previous day of trading, before settling in for the closing price of $1.80. CMPX’s price has ranged from $0.76 to $2.34 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -26.41%. With a float of $85.81 million, this company’s outstanding shares have now reached $127.67 million.
Let’s look at the performance matrix of the company that is accounted for 32 employees. In terms of profitability, gross margin is 34.18%, operating margin of -1878.55%, and the pretax margin is -1597.89%.
Compass Therapeutics Inc (CMPX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Compass Therapeutics Inc is 37.63%, while institutional ownership is 41.26%.
Compass Therapeutics Inc (CMPX) Latest Financial update
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.08 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -26.41% per share during the next fiscal year.
Compass Therapeutics Inc (NASDAQ: CMPX) Trading Performance Indicators
Here are Compass Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 16.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 300.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.48 in one year’s time.
Technical Analysis of Compass Therapeutics Inc (CMPX)
Compass Therapeutics Inc (NASDAQ: CMPX) saw its 5-day average volume 0.64 million, a positive change from its year-to-date volume of 0.43 million. As of the previous 9 days, the stock’s Stochastic %D was 73.88%. Additionally, its Average True Range was 0.14.
During the past 100 days, Compass Therapeutics Inc’s (CMPX) raw stochastic average was set at 86.31%, which indicates a significant increase from 76.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.95% in the past 14 days, which was lower than the 90.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7448, while its 200-day Moving Average is $1.5168. Nevertheless, the first resistance level for the watch stands at $1.9967 in the near term. At $2.0933, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.1867. If the price goes on to break the first support level at $1.8067, it is likely to go to the next support level at $1.7133. The third support level lies at $1.6167 if the price breaches the second support level.
Compass Therapeutics Inc (NASDAQ: CMPX) Key Stats
With a market capitalization of 255.74 million, the company has a total of 137,589K Shares Outstanding. Currently, annual sales are 0 K while annual income is -42,490 K. The company’s previous quarter sales were 850 K while its latest quarter income was -13,080 K.
